SMTL ID : 8h07.1

SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-3-3-mer

Ligands

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 6 residues within 4Å: Chain A: D.337, N.341, F.369 Chain N: W.103, H.104, W.105 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.337 NAG.2: 6 residues within 4Å: Chain B: D.337, N.341, F.369 Chain J: W.103, H.104, W.105 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:D.337 NAG.3: 6 residues within 4Å: Chain C: D.337, N.341, F.369 Chain F: W.103, H.104, W.105 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:D.337

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, Y. et al., Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants. Nat Commun (2023)

Release Date

2023-05-31

Peptides

Spike glycoprotein: ABC
10-5B H chain: DHL
10-5B L chain: EIM
6-2C H chain: FJN
6-2C L chain: GKO

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
E

H
G

L
M

E
J

I
H

M
P

F
N

J
I

N
Q

G
O

K
K

O
R

Spike glycoprotein

10-5B H chain

10-5B L chain

6-2C H chain

6-2C L chain

Related Entries With Identical Sequence